ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $13,880,000 | -50.5% | 1,000,000 | 0.0% | 0.62% | -21.4% |
| Q4 2021 | $28,060,000 | -42.7% | 1,000,000 | -30.6% | 0.79% | -35.1% |
| Q3 2021 | $48,946,000 | -16.8% | 1,440,000 | 0.0% | 1.22% | -18.5% |
| Q2 2021 | $58,838,000 | +27.1% | 1,440,000 | +25.2% | 1.49% | +8.3% |
| Q1 2021 | $46,299,000 | +9.8% | 1,150,000 | +61.3% | 1.38% | +10.4% |
| Q4 2020 | $42,167,000 | +21.6% | 713,125 | 0.0% | 1.25% | -19.6% |
| Q3 2020 | $34,679,000 | +0.5% | 713,125 | 0.0% | 1.55% | -23.9% |
| Q2 2020 | $34,501,000 | +56.6% | 713,125 | -10.1% | 2.04% | -12.7% |
| Q1 2020 | $22,033,000 | +59.0% | 793,125 | +71.3% | 2.34% | +83.6% |
| Q4 2019 | $13,857,000 | -99.9% | 463,125 | 0.0% | 1.27% | -14.0% |
| Q3 2019 | $14,310,562,000 | -28.8% | 463,125 | 0.0% | 1.48% | -21.3% |
| Q2 2019 | $20,100,347,000 | – | 463,125 | – | 1.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |